1. 120 LYMPHADENECTOMY ALONG THE LEFT RECURRENT LARYNGEAL NERVE AFTER ESOPHAGEAL STRIPPING. (14th September 2020) Authors: Makino, H; Nomura, S; Maruyama, H; Yokoyama, T; Hirakata, A; Takata, H; Kogo, H; Iwai, T; Yoshioka, M; Yoshida, H Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1424PThe plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial). (23rd October 2018) Authors: Usui, K; Yokoyama, T; Kisohara, A; Mori, Y; Takeda, Y; Ishida, H; Kusano, N; Kishi, K; Katsushima, U; Kuwako, T; Aono, H; Shikama, Y; Minato, K; Matsushima, H; Uemura, K; Ohashi, Y; Kunitoh, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1436PRandomized phase II study comparing cisplatin + pemetrexed + bevacizumab with carboplatin + paclitaxel + bevacizumab in treatment-naïve advanced non-squamous non-small cell lung cancer (CLEAR study). (23rd October 2018) Authors: Koyama, R; Udagawa, H; Sugiyama, E; Komuta, K; Mori, M; Yokoyama, T; Sasaki, T; Saito, H; Ishida, H; Nakagawa, H; Sekine, A; Tamura, A; Shingyoji, M; Mizuno, K; Nakamura, A; Kinoshita, A; Yamanaka, T; Goto, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1501TiPAfatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study). (23rd October 2018) Authors: Hata, A; Katakami, N; Nishino, K; Mori, M; Yokoyama, T; Kurata, T; Tachihara, M; Takase, N; Daga, H; Kijima, T; Morita, S; Sakai, K; Nishio, K; Satouchi, M; Negoro, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 481PUpdated survival outcomes of the phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small cell lung cancer (KTORG1402). (24th November 2019) Authors: Yokoyama, T; Yoshioka, H; Fujimoto, D; Demura, Y; Hirano, K; Kawai, T; Kagami, R; Ishida, T; Tomii, K; Akai, M; Hirabayashi, M; Nishimura, T; Nakahara, Y; Kim, Y H; Yoshimura, K; Hirai, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 511PPhase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402). (24th November 2019) Authors: Kubo, T; Nogami, N; Bessho, A; Morita, A; Ikeo, S; Yokoyama, T; Ishihara, M; Honda, T; Fujimoto, N; Murakami, S; Kaira, K; Harada, T; Nakamura, K; Iwasawa, S; Shimokawa, T; Kiura, K; Yamashita, N; Okamoto, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 522PWeekly nab-PTX and weekly PTX for relapsed small cell lung cancer. (24th November 2019) Authors: Oi, H; Yamano, Y; Yokoyama, T; Matsuda, T; Morise, M; Kataoka, K; Kimura, T; Kondoh, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 540PClinical outcomes in non–small cell lung cancer patients with ultra-high expression of programmed death ligand-1 treated with pembrolizumab as first-line therapy: A retrospective multicenter cohort study. (25th November 2018) Authors: Kurebe, H; Edahiro, R; Kanazu, M; Fujimoto, D; Tamiya, M; Tamiya, A; Suzuki, H; Hirano, K; Yokoyama, T; Morita, M; Fukuda, Y; Uchida, J; Makio, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. (June 2014) Authors: Yokoyama, T; Fujii, T; Kondo-Ishikawa, S; Yamakawa, N; Nakano, M; Yukawa, N; Yoshifuji, H; Ohmura, K; Mimori, T Journal: Lupus Issue: Volume 23:Number 7(2014) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy. Issue 1 (December 2015) Authors: Makino, S; Kita, H; Miyatake, Y; Yokoyama, T; Kubota, K; Obata, N; Egi, M; Misumi, T; Izuta, S; Mizobuchi, S Journal: Critical care Issue: Volume 19:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗